[Pharmacology of isopropylidene-proscillaridin].
D000818:Animals; D001693:Biological Transport, Active / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002301:Cardiac Glycosides / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D002415:Cats; D002463:Cell Membrane Permeability / Q000187:drug effects; D003864:Depression, Chemical; D004912:Erythrocytes / Q000032:analysis; D005260:Female; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D010210:Papillary Muscles / Q000187:drug effects; D011188:Potassium / Q000032:analysis / Q000037:antagonists & inhibitors; D051381:Rats; D012964:Sodium / Q000032:analysis / Q000037:antagonists & inhibitors; D013268:Stimulation, Chemical
D002301:Cardiac Glycosides; D012964:Sodium; D011188:Potassium
Zur Pharmakologie von Isopropyliden-Proscillaridin.